YESMERIQ Trademark

Trademark Overview


On Friday, April 25, 2025, a trademark application was filed for YESMERIQ with the United States Patent and Trademark Office. The USPTO has given the YESMERIQ trademark a serial number of 99155779. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 10, 2026. This trademark is owned by Longboard Pharmaceuticals, Inc.. The YESMERIQ trademark is filed in the Pharmaceutical Products category with the following description:

Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's diseas...
yesmeriq

General Information


Serial Number99155779
Word MarkYESMERIQ
Filing DateFriday, April 25, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 10, 2026

Trademark Statements


Goods and ServicesSanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and/or treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 25, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLongboard Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameLongboard Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Friday, April 25, 2025NEW APPLICATION ENTERED
Friday, April 25, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 17, 2025ASSIGNED TO EXAMINER
Thursday, September 18, 2025NON-FINAL ACTION WRITTEN
Thursday, September 18, 2025NON-FINAL ACTION E-MAILED
Thursday, September 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 20, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 20, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, January 20, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 20, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, January 20, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 4, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 10, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 10, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED